Evidence map›Paper›PMID 33659992›Full record

ArticleInternational journal of epidemiology2021

Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults.

Blake Thomson, Roberto Tapia-Conyer, Ben Lacey, Sarah Lewington, Raúl Ramirez-Reyes, Diego Aguilar-Ramirez, Louisa Gnatiuc, William G Herrington, Jason Torres, Eirini Trichia and 6 more

Abstract read
In one paragraph

Article in International journal of epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Blake ThomsonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-6433-0338
Roberto Tapia-ConyerSchool of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID 0000-0003-3814-2904
Ben LaceyClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0003-0139-2934
Sarah LewingtonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-4496-4771
Raúl Ramirez-ReyesSchool of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID 0000-0001-9763-324X
Diego Aguilar-RamirezClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0003-2298-3768
Louisa GnatiucClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-0641-2220
William G HerringtonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0003-1172-8243
Jason TorresClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-7537-7035
Eirini TrichiaClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0002-7655-5905
Rachel WadeClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-9826-6322
Rory CollinsClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-8288-8602
Richard PetoClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-8219-5339
Pablo Kuri-MoralesSchool of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID 0000-0002-0704-9507
Jesus Alegre-DíazSchool of Medicine, National Autonomous University of Mexico (UNAM), Mexico City, Mexico.ORCID 0000-0001-9390-3871
Jonathan R EmbersonClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, UK.ORCID 0000-0001-7792-9422

Funding

British Heart Foundation RE/13/1/30181Cancer Research UKMedical Research Council MC_UU_00017/2Medical Research Council MR/R007764/1Wellcome Trust
6 · The paper itself

Abstract

backgroundResearch is needed to determine the relevance of low-intensity daily smoking to mortality in countries such as Mexico, where such smoking habits are common.

methodsProspective study of 159 755 Mexican adults recruited from 1998-2004 and followed for cause-specific mortality to 1 January 2018. Participants were categorized according to baseline self-reported smoking status. Confounder-adjusted mortality rate ratios (RRs) at ages 35-89 were estimated using Cox regression, after excluding those with previous chronic disease (to avoid reverse causality).

resultsAmong 42 416 men and 86 735 women aged 35-89 and without previous disease, 18 985 men (45%) and 18 072 women (21%) reported current smoking and 8866 men (21%) and 53 912 women (62%) reported never smoking. Smoking less than daily was common: 33% of male current smokers and 39% of female current smokers. During follow-up, the all-cause mortality RRs associated with the baseline smoking categories of <10 cigarettes per day (average during follow-up 4 per day) or ≥10 cigarettes per day (average during follow-up 10 per day), compared with never smoking, were 1.17 (95% confidence interval 1.10-1.25) and 1.54 (1.42-1.67), respectively. RRs were similar irrespective of age or sex. The diseases most strongly associated with daily smoking were respiratory cancers, chronic obstructive pulmonary disease and gastrointestinal and vascular diseases. Ex-daily smokers had substantially lower mortality rates than those who were current daily smokers at recruitment.

conclusionsIn this Mexican population, low-intensity daily smoking was associated with increased mortality. Of those smoking 10 cigarettes per day on average, about one-third were killed by their habit. Quitting substantially reduced these risks.

Indexed as

SmokingTobacco SmokingAdultAgedAged, 80 and overCause of DeathFemaleHumansMaleMexicoMiddle AgedProspective Studiescause-specific mortalitycohort studyMexicoSmoking

Identifiers

PMID33659992
PMCPMC8271211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.